Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis

Liver Transplantation

Volumn 17, Issue 7, 2011, Pages 779-788

  Aguilera, Isabel ^a   Sousa, José Manuel ^a   Gavilan, Francisco ^a   Gomez, Lourdes ^a   Alvarez Márquez, Antonia ^a   Núñez Roldán, Antonio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT COMPONENT C4D; GLUTATHIONE TRANSFERASE T1;

ADULT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DE NOVO IMMUNE HEPATITIS; FEMALE; GENOTYPE; GRAFT DYSFUNCTION; HEPATITIS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER SINUSOID; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECIPIENT; RECURRENCE RISK; RETROSPECTIVE STUDY; WILD TYPE;

ADULT; AGED; BIOPSY; COMPLEMENT C4B; FEMALE; GLUTATHIONE TRANSFERASE; HEPATITIS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 79959839260     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22302     Document Type: Article

References (26)

1. Evans HM, Kelly DA, McKiernan PJ, Hubscher S,. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006; 43: 1109-1117. (Pubitemid 43724635)
2. Kerkar N, HadziÄ? N, Davies ET, Portmann B, Donaldson PT, Rela M, et al. De novo autoimmune hepatitis after liver transplantation. Lancet 1998; 351: 409-413. (Pubitemid 28064165)
3. Heneghan MA, Portmann BC, Norris SM, Williams R, Muiesan P, Rela M, et al. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology 2001; 34: 464-470. (Pubitemid 32791325)
4. Andries S, Casamayou L, Sempoux C, Burlet M, Reding R, Bernard Otte J, et al. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Transplantation 2001; 72: 267-272. (Pubitemid 32729347)
5. Banff Working Group,. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006; 44: 489-501.
6. Aguilera I, Wichmann I, Sousa JM, Bernardos A, Franco E, García-Lozano JR, NÃ?ñez-Roldán A,. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation. Clin Exp Immunol 2001; 126: 535-539. (Pubitemid 34008729)
7. Aguilera I, Sousa JM, Gavilan F, Bernardos A, Wichmann I, Nuñez-Roldán A,. Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Liver Transpl 2004; 10: 1166-1172. (Pubitemid 39255364)
8. Rodriguez-Mahou M, Salcedo M, Fernandez-Cruz E, Tiscar JL, Bañares R, Clemente G, et al. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with GSTT1 null genotype as prognostic marker: long-term follow-up after liver transplantation. Transplantation 2007; 83: 1126-1129. (Pubitemid 46659126)
9. Feucht HE, Schneeberger H, Hillebrand G, Burkhardt K, Weiss M, Riethmüller G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333-1338. (Pubitemid 23161421)
10. Feucht HE,. Complement C4d in graft capillariesâthe missing link in the recognition of humoral alloreactivity. Am J Transplant 2003; 3: 646-652. (Pubitemid 36745236)
11. Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Williams WW, Tolkoff-Rubin N, et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 2208-2214. (Pubitemid 29453499)
12. Regele H, Böhmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S, et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 2371-2380. (Pubitemid 34925248)
13. Poduval RD, Kadambi PV, Josephson MA, Cohn RA, Harland RC, Javaid B, et al. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation 2005; 79: 228-235.
14. Colvin RB, Smith RN,. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5: 807-817. (Pubitemid 41400854)
15. Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan S, Kobashigawa J, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 1033-1041. (Pubitemid 38868592)
16. Neil DA, Hübscher SG,. Current views on rejection pathology in liver transplantation. Transpl Int 2010; 23: 971-983.
17. Haga H, Egawa H, Fujimoto Y, Ueda M, Miyagawa-Hayashino A, Sakurai T, et al. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl 2006; 12: 457-464.
18. Schmeding M, Dankof A, Krenn V, Krukemeyer MG, Koch M, Spinelli A, et al. C4d in acute rejection after liver transplantationâa valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant 2006; 6: 523-530. (Pubitemid 43382138)
19. Dankof A, Schmeding M, Morawietz L, Günther R, Krukemeyer MG, Rudolph B, et al. Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection. Virchows Arch 2005; 447: 87-93. (Pubitemid 41126244)
20. Sawada T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S,. Lobular damage caused by cellular and humoral immunity in liver allograft rejection. Clin Transplant 2005; 19: 110-114. (Pubitemid 40227861)
21. Jain A, Ryan C, Mohanka R, Orloff M, Abt P, Romano J, et al. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies. Clin Transplant 2006; 20: 624-633. (Pubitemid 44383409)
22. Dubel L, Farges O, Johanet C, Sebagh M, Bismuth H,. High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation 1998; 65: 1072-1075. (Pubitemid 28208426)
23. Riva S, Sonzogni A, Bravi M, Bertani A, Alessio MG, Candusso M, et al. Late graft dysfunction and autoantibodies alter liver transplantation in children: preliminary results of an Italian experience. Liver Transpl 2006; 12: 573-577.
24. Sakashita H, Haga H, Ashihara E, Wen MC, Tsuji H, Miyagawa-Hayashino A, et al. Significance of C4d staining in ABO-identical/compatible liver transplantation. Mod Pathol 2007; 20: 676-684. (Pubitemid 46788874)
25. Martelius T, Halme L, Arola J, Höckerstedt K, Lautenschlager I,. Vascular deposition of complement C4d is increased in liver allografts with chronic rejection. Transpl Immunol 2009; 2 1: 244-246.
26. Krukemeyer MG, Moeller J, Morawietz L, Rudolph B, Neumann U, Theruvath T, et al. Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection. Transplantation 2004; 78: 65-70.